Stem cell therapy furthers research for infants with hypoplastic left heart syndrome
A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome (HLHS) through collecting, processing ...
Jul 23, 2019
0
2